Your browser doesn't support javascript.
loading
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
Canonici, Alexandra; Browne, Alacoque L; Ibrahim, Mohamed F K; Fanning, Kevin P; Roche, Sandra; Conlon, Neil T; O'Neill, Fiona; Meiller, Justine; Cremona, Mattia; Morgan, Clare; Hennessy, Bryan T; Eustace, Alex J; Solca, Flavio; O'Donovan, Norma; Crown, John.
Afiliação
  • Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Browne AL; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Ibrahim MFK; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Fanning KP; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Roche S; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • O'Neill F; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Meiller J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Cremona M; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Morgan C; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Whitehall, Glasnevin, Dublin 9, Ireland.
  • Solca F; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Ther Adv Med Oncol ; 12: 1758835919897546, 2020.
Article em En | MEDLINE | ID: mdl-32064003
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article